Skip to content

Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers

Randomized Study Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function, Autonomic Nervous System, Insulin Sensitivity and Carbohydrate Metabolism

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02185729
Acronym
TPN1
Enrollment
12
Registered
2014-07-10
Start date
2008-06-30
Completion date
2012-03-31
Last updated
2014-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases, Metabolic, Insulin Sensitivity

Keywords

Intravenous Feeding, Lipid Emulsions, Intravenous

Brief summary

Many patients in the hospital who are malnourished or not eating received intravenous feeding or total parenteral nutrition (TPN). Despite improving nutrition, TPN may increase the risk of infections and hospital complications. We do not know why TPN increases hospital complications, but it may be caused by the high sugar or fat content in TPN solutions. The investigators believe that the high sugar and high fat content can limit the ability to fight infections and produce stiffness of blood vessels. This study will compare the effect of high sugar, high fat content or both on blood sugars, blood vessel function, on blood vessel function. The investigators will also compare the effect of different fats (olive oil and soybean) in the TPN solution on the risk of infection and blood vessel function on a total of 12 healthy subjects.

Interventions

DRUGIntralipid

Infusion of Intralipid (soybean-derived fat)

Infusion of ClinOleic (olive oil-based)

DRUGDextrose

Infusion of dextrose (sugar) without fat

OTHERSaline (control)

Infusion of 0.9% normal saline

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
Emory University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males or females, BMI 25 - 35 kg/m2, between the ages of 18 and 65 years

Exclusion criteria

* The patient is pregnant or breast feeding * Subjects have or with history of diabetes, hypertension, fasting triglyceride levels \> 250 mg/dL, liver disease (ALT 2.5x \> upper limit of normal), serum creatinine ≥1.5 mg/dL * Smokers or ex-smoker \< 3 months of cessation, drug or alcohol abuse * Mental condition rendering the subject unable to understand the scope and possible consequences of the study.

Design outcomes

Primary

MeasureTime frameDescription
Flow Mediated DilationBaselineEndothelium-dependent brachial artery flow-mediated dilation (FMD) was assessed. Ultrasound images of the brachial artery were obtained and arterial diameters were measured with customized software. Brachial artery FMD was calculated as (hyperemic diameter - baseline diameter)/baseline diameter × 100.

Countries

United States

Participant flow

Recruitment details

All subjects seen at Grady Memorial Hospital Clinical Interactions Network unit of the Atlanta Clinical and Translational Science Institute. Subjects were admitted on the afternoon before the study protocol began.

Pre-assignment details

An overnight fast, subjects underwent research studies in the morning with the infusion starting between 1200 and 1300 h.

Participants by arm

ArmCount
Healthy Volunteer
Healthy subjects receive 24-hour TPN infusion of Intralipid (soybean-derived fat), ClinOleic (olive oil), dextrose (sugar) without fat, and a 24-hour infusion of normal saline (control) Intralipid ClinOleic Dextrose Saline (control)
12
Total12

Baseline characteristics

CharacteristicHealthy Volunteer
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Age, Continuous41 years
STANDARD_DEVIATION 7
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Flow Mediated Dilation

Endothelium-dependent brachial artery flow-mediated dilation (FMD) was assessed. Ultrasound images of the brachial artery were obtained and arterial diameters were measured with customized software. Brachial artery FMD was calculated as (hyperemic diameter - baseline diameter)/baseline diameter × 100.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
IntralipidFlow Mediated Dilation10.3 percentage of brachial artery diameterStandard Error 0.88
ClinOleicFlow Mediated Dilation8.9 percentage of brachial artery diameterStandard Error 0.8
DextroseFlow Mediated Dilation9.2 percentage of brachial artery diameterStandard Error 0.72
SalineFlow Mediated Dilation9.1 percentage of brachial artery diameterStandard Error 0.58
Primary

Flow Mediated Dilation

Endothelium-dependent brachial artery flow-mediated dilation (FMD) was assessed. Ultrasound images of the brachial artery were obtained and arterial diameters were measured with customized software. Brachial artery FMD was calculated as (hyperemic diameter - 4 hour diameter)/4 hour diameter × 100.

Time frame: 4 hours after infusion

ArmMeasureValue (MEAN)Dispersion
IntralipidFlow Mediated Dilation7.9 percentage of brachial artery diameterStandard Error 0.83
ClinOleicFlow Mediated Dilation9.0 percentage of brachial artery diameterStandard Error 0.88
DextroseFlow Mediated Dilation8.3 percentage of brachial artery diameterStandard Error 0.67
SalineFlow Mediated Dilation8.2 percentage of brachial artery diameterStandard Error 1.37
Primary

Flow Mediated Dilation

Endothelium-dependent brachial artery flow-mediated dilation (FMD) was assessed. Ultrasound images of the brachial artery were obtained and arterial diameters were measured with customized software. Brachial artery FMD was calculated as (hyperemic diameter - 24 hour diameter)/24 hour diameter × 100.

Time frame: 24 hours after infusion

ArmMeasureValue (MEAN)Dispersion
IntralipidFlow Mediated Dilation7.2 percentage of brachial artery diameterStandard Error 0.74
ClinOleicFlow Mediated Dilation9.1 percentage of brachial artery diameterStandard Error 0.91
DextroseFlow Mediated Dilation10.2 percentage of brachial artery diameterStandard Error 1.15
SalineFlow Mediated Dilation9.7 percentage of brachial artery diameterStandard Error 0.89

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026